Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler.

Dave SinghFrans van den BergBrian LeakerMassimo Corradi Sunny Jabbal Sara CollariniValentina MongelliLuigi SantoroAnnalisa PiccinnoSonia BiondaroBrian Lipworth

Published in: British journal of clinical pharmacology (2019)

Extrafine Foster® NEXThaler, a flow-independent DPI, is comparable to extrafine Foster® pMDI when administered as reliever therapy after methacholine challenge, thus supporting the maintenance and reliever therapy approach also with Foster® NEXThaler.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic obstructive pulmonary disease
peritoneal dialysis
stem cells
lung function
patient reported outcomes
bone marrow
cell therapy
endothelial cells
mesenchymal stem cells